Immunology Quiz#25: Immunotherapies

1. A 45-year-old woman with severe rheumatoid arthritis has failed to respond to conventional DMARDs. Her rheumatologist decides to initiate treatment with a biologic agent that targets TNF-α. Which of the following drugs is she most likely being prescribed? 

Question 1 of 5

2. A 30-year-old man with moderate to severe plaque psoriasis is started on a new medication that targets the p40 subunit of IL-12 and IL-23. Which of the following medications has he most likely been prescribed? 

Question 2 of 5

3. A 25-year-old woman with multiple sclerosis is started on a medication that selectively targets CD20-positive B cells. Which of the following drugs is she most likely receiving? 

Question 3 of 5

4. A 55-year-old man with chronic lymphocytic leukemia (CLL) is treated with a monoclonal antibody that targets CD52, a protein expressed on the surface of mature lymphocytes. Which of the following drugs is being used? 

Question 4 of 5

5. A 40-year-old woman with moderate to severe Crohn's disease is started on an immunobiologic therapy that inhibits the integrin α4β7, thereby preventing leukocyte adhesion and migration into inflamed gut tissue. Which of the following medications has she most likely been prescribed? 

Question 5 of 5


 

¡Por tiempo limitado!

Unete a nuestro boletín mensual y obtén todos nuestros talleres USMLE/ECFMG ¡GRATIS! (+100 videos)

¡Únete a nuestra comunidad de IMGs!

¡Obtén actualizaciones mensuales USMLE y ECFMG, además, obtén un taller USMLE gratis al instante!

"Taller 01: ¿Qué es el USMLE?”

Taller Gratuito USMLE

Este taller proporciona un análisis en profundidad de todos los exámenes USMLE, consejos para tomar exámenes y cómo estudiar de manera efectiva.

OFERTA POR TIEMPO LIMITADO

Especialista ECFMG: Dr. Carla Rebeca Lainez Casal

Facultad de Medicina: Universidad Catholica de Santiago de Guayaquil
ECFMG Certification date: October 13, 2022.
Residency: 2023 Internal Medicine Applicant
+1 7542724970